Capital Research Global Investors
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1422848
Los Angeles, CA
Position in BIO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$130,211,043
+$22,730,897 QoQ
Shares Held
443,483
+15.0% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 397 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $5,763,070,648 across 10 Medical Devices names. BIO ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
36,908,990 | $3,349,121,752 | |
| 2 | MDT |
Medtronic plc
|
13,261,310 | $1,037,432,281 | |
| 3 | BSX |
Boston Scientific Corp
|
14,180,571 | $605,226,770 | |
| 4 | SYK |
Stryker Corp
|
1,617,176 | $509,151,691 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
443,483 | $130,211,043 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
|
335,209 | $39,873,110 | |
| 7 | CNMD |
CONMED Corp
|
823,636 | $26,957,606 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
394,148 | $25,229,413 |
All Filings in BIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,211,043 | 443,483 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $107,480,146 | 385,579 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $149,820,071 | 494,472 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $117,302,558 | 418,355 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||